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UCH Can be inferred about the function of a pro- 
tein in vivo from its biochemical properties and 
its  intracellular  localization.  The  acid  test  for 
function in vivo, however, is the creation of mutant cell lines 
in which the protein of interest is either missing or nonfunc- 
tional and the analysis of the behavioral abnormalities ex- 
hibited by these mutant cells. One of the most dramatic suc- 
cesses in the use of  this approach for the study of  cell motility 
was  the  demonstration  in  1987  that Dictyostelium ceils 
which lack the heavy chain polypeptide for the conventional 
form of nonmuscle myosin, myosin 11, have profound blocks 
in cytokinesis when grown in suspension and in multicellnlar 
development (6, 12). This elegant work was greatly aided by 
the simple fact that in Dictyostelium there is a single gene 
for the heavy chain of conventional myosin, so ablation of 
this gene or suppression  of its expression with antisense 
RNA renders a cell that is missing an entire class of nonmus- 
cle myosin. Subsequent work by a number of labs has shown 
that myosin II- cells are also unable to cap surface recep- 
tors crosslinked with Con A (22), have greatly reduced corti- 
cal stiffness (22), and are inefficient in cell locomotion and 
chemotaxis (37) (for review see reference 28). The fact that 
myosin 11- cells exhibit these striking phenotypes, that wild 
type and mutated copies of the myosin II gene can be intro- 
duced  into  myosin II-  cells,  and  that  rescue  of the  be- 
havioral abnormalities can be readily assayed, has opened 
the door to in vivo structure/function analyses of the myosin 
1I heavy chain (7, 26, 35). 
Dictyostelium myosin 11 is phosphorylated in vivo on both 
its heavy and light chains (1, 2, 15), and in vitro data indicate 
that these phosphorylations regulate the actin-activated  ATP- 
ase, self-assembly properties, and motility properties of the 
molecule (for review see references 13 and 31). In the last 
several years, therefore, efforts  by several  labs have been 
directed  at  ascertaining  the  relative  importance of these 
phosphorylations in vivo. In this short review, I will summa- 
rize the current in vitro data regarding the effects of heavy 
and light chain phosphorylation on Dictyostelium  myosin 11, 
and recent efforts to define the significance of these phos- 
phorylations in living cells. 
For heavy chain phosphorylation, a myosin II heavy chain 
kinase expressed  in vegetative ceils phosphorylates three 
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threonine residues (residues 1823, 1833, and 2029) within 
the  carboxyl-terminal portion of the myosin II c~ helical 
coiled-coil tail, which is the portion of the molecule that 
mediates self-assembly of myosin 11 monomers into small 
bipolar filaments (4,  18, 36).  Myosin 11 molecules that are 
fully phosphorylated at all three sites are profoundly im- 
paired in their ability to self-assemble into bipolar filaments 
at all ionic strengths (5,  15,  16, 23). A second heavy chain 
kinase,  which is expressed only in developing cells,  and 
whose sites of phosphorylation are unknown, has a similar 
effect on assembly properties (23).  Heavy chain phosphory- 
lation has also been reported to inhibit actin-activated ATP- 
ase activity, but this is almost certainly a consequence of the 
inhibition of filament formation (4, 32). Heavy chain phos- 
phorylation may block filament formation by stabilizing a 
bent, assembly-incompetent form of myosin 1I (21, 31). 
Egelhoff and colleagues (8)  expressed  in a  myosin 11- 
background myosin 11 heavy chains in which the three threo- 
nine residues were changed to either nonphosphorylatable 
alanine residues ("3XALA" myosin), or to aspartate residues 
("3XASP" myosin). In the latter case, it was hoped that the 
negative charge on the aspartate residue would mimic phos- 
phorylated threonine, thereby generating in a  constitutive 
way "fully phosphorylated" myosin II. As anticipated, the 
3XASP  myosin was essentially incapable of forming fila- 
ments in vitro, while the 3XALA myosin assembled as well 
as wild type myosin "as isolated  ~, or perhaps slightly better. 
These  in  vitro differences were mirrored in vivo,  where 
3XALA myosin was shown by analysis of triton-insoluble 
cytoskeletons to be dramatically over assembled relative to 
wild type myosin, while 3XASP myosin was under assem- 
bled. These differences in assembly state were also reflected 
in the extent and duration of myosin II localization at Con 
A caps. The most dramatic difference between these two en- 
gineered myosins, however, was that while 3XALA myosin 
was able to rescue the profound defects in cytokinesis, devel- 
opment and receptor capping found in myosin II null cells, 
the 3XASP myosin was not. One important conclusion from 
this work, therefore, is that the assembly of myosin II into 
bipolar filaments is a prerequisite for myosin II function in 
vivo.  This conclusion was presaged by the early work of 
Delozanne and Spudich (6), who created Dictyostelium  cells 
that make the heavy meromyosin (HMM) ~  fragment of my- 
1. Abbreviations used in this paper: HMM, heavy mermyosin; MLCK, my- 
osin light chain kinase;  RLC,  regulatory light chain. 
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port movement in vitro when artificially anchored to a sur- 
face, it cannot assemble into filaments (31). Consistent with 
this, HMM cells are indistinguishable phenotypically from 
heavy chain null cells (6,  19). 
A  second important conclusion from Egelhoft's work is 
that the ability to place phosphates on the three threonine 
residues in the tail is not essential for myosin II function. 
This does not mean that constitutively dephosphorylated my- 
osin II works as well in vivo as myosin II which can be regu- 
lated by heavy chain phosphorylation. Indeed, some abnor- 
malities in growth rate were reported for 3XALA myosin 
(most likely due to the over-assembly of this myosin) (8). 
Other subtle abnormalities would almost certainly be de- 
tected by further detailed analysis of  these cells, since spatial 
and temporal changes in the assembly state of myosin II on 
a rapid time scale (i.e., seconds) are likely to be important 
for optimal execution of myosin H-dependent processes. It 
means simply that Dictyostelium cells can perform several 
functions that are absolutely dependent on myosin II when 
they express a myosin II that cannot be phosphorylated on 
its heavy chain. 
Now, in two papers appearing in this issue (3, 20),  Rex 
Chisholm's laboratory has explored the significance of the 
regulatory light chain subunit for myosin II structure and 
function, and, even more interestingly, the relative impor- 
tance of regulatory light chain (RLC) phosphorylation in 
vivo. In the first paper (3), mutant cells which do not express 
the ,018-kD RLC were created by targeted disruption of the 
single-copy RLC gene, and these cells were then shown to 
resemble in most ways the behavior of myosin II heavy chain 
null cells (the sole difference being that RLC cells can still 
cap Con A-crosslinked surface receptors). These results, to- 
gether with the recent work of Uyeda and Spudich (35), shed 
considerable light on the role that the RLC plays  i n the struc- 
ture of the neck domain and the ability of the Dictyostelium 
myosin II head to function as a mechanoenzyme (see refer- 
ences 35 and 25).  The results in the first paper also served 
to lay the ground work for the second paper (20), in which 
a comparison was made between the behavior of RLC- cells 
that were rescued with either wild type RLC or  a  non- 
phosphorylatable RLC. But before we get into this interest- 
ing story, a review of the in vitro data regarding the role of 
RLC phosphorylation in regulating Dictyostelium  myosin II 
is in order. 
In an early paper by Griflith et al.  (10),  evidence was 
presented using a  partially purified Dictyostelium myosin 
light chain kinase (MLCK) that phosphorylation of the myo- 
sin II RLC regulates both the actin-activated ATPase and 
mechanochemical properties of  myosin II. With regard to the 
actin-activated ATPase,  myosin II whose RLC was com- 
pletely dephosphorylated (<0.1 mole phosphate/mole RLC) 
following  treatment with a protein phosphatase could be acti- 
vated approximately sixfold (from "o20 nmoles/min/mg to 
"o120 nmoles/min/mg at high actin concentrations) by phos- 
phorylating the myosin to ,01  mole phosphate/mole RLC 
(note that these and other ATPase numbers below are steady 
state values, not single turnover numbers, so the fold activa- 
tion  could be  under  estimated).  Myosin II "as  isolated" 
which typically has ,o0.3 moles phosphate/mole RLC, had 
an  intermediate  specific  activity  (,060  nmoles/min/mg). 
This degree of regulation has been largely reproduced by 
Ruppel et al.  (26)  and Uyeda and Spudich (35)  using the 
same MLCK, except that the kinase has now been expressed 
in Escherichia coli and purified to homogeneity (29, 30). In- 
terestingly, Uyeda and Spudich (35) also showed that myosin 
in which the 30-residue portion of the heavy chain that con- 
tains the RLC binding site had been deleted, has an "02.5- 
fold higher actin-activated ATPase activity than maximally 
activated wild type myosin. This result suggests  that the 
complex of the RLC and its binding site within the "neck  ~ 
domain of the myosin head serves to inhibit ATPase activity 
and that phosphorylation of the RLC partially derepresses 
this inhibition. In summary, then, it appears clear that phos- 
phorylation of the  Dictyostelium myosin  II  RLC  has  a 
significant  effect on actin-activated ATPase activity. It is also 
clear, however, that unphosphorylated myosin II has a "rea- 
sonable"  steady  state  actin-activated  ATPase  activity 
(,'o15-20%  of the fully phosphorylated protein), and that the 
approximately sixfold activation of Dictyostelium myosin II 
by RLC phosphorylation is at least one order of magnitude 
less than the fold activation of smooth muscle and vertebrate 
nonmuscle myosins II by Ca  ~+/ealmedulin-dependent MLCK 
(using steady state ATPase numbers) (for review see refer- 
ences 27 and 31). Furthermore, while phosphorylation of the 
RLC of smooth muscle and vertebrate nonmuscle myosins 
converts folded, assembly-incompetent myosin (6S myosin) 
into  unfolded,  assembly-competent myosin (10S myosin) 
(34),  phosphorylation of the Dictyostelium myosin II RLC 
does not appear to influence the assembly properties of the 
protein (10, 31). 
With regard to the effect  of RLC phosphorylation on motil- 
ity, Griflith et al. (10) assayed for mechanochemical activity 
using myosin II-coated beads and the Nitella-based motility 
assay. Using their partially purified MLCK, they showed that 
beads coated with myosin "as isolated" moved at "01 #m/sec, 
while beads coated with fully phosphorylated myosin moved 
at ,ol.4 #m/s. This degree of activation of myosin -as isolated" 
by MLCK (,01.5-fold)  has  subsequently been reproduced 
with the cloned, purified MLCK, and the Kron/Spudich- 
type (14) motility assay (35).  Of much greater significance 
is the fact that when Griffith et al. (10) coated beads with 
completely dephosphorylated myosin, they saw essentially 
no movement of the beads. This important result, which im- 
plies that RLC phosphorylation is absolutely required for 
myosin II to exhibit mechanochemical activity, has unfortu- 
nately not been repeated in the literature (the study by Uyeda 
and Spudich mentioned above [35] was done with partially 
phosphorylated myosin and fully phosphorylated myosin, 
but not with dephosphorylated myosin). The current situa- 
tion would be remedied by a careful experiment in which 
completely dephosphorylated myosin II is phosphorylated 
with pure MLCK to various stoichiometries (ranging from 
0-'1 mole phosphate/mole RLC), and the speed with which 
these various samples move actin measured in the Kron/ 
Spudich motility assay. As discussed in more detail below, 
such an experiment would shed additional light on the mean- 
ing of the RLC rescue experiments described by Ostrow et 
al. (20) in this issue. 
So it is against this back drop of in vitro data that Ostrow 
et al. (20)  set out on their RLC rescue experiments. After 
first establishing that wild type RLCs would rescue the se- 
vere phenotype of RLC- cells, they then set out to deter- 
mine if successful rescue requires that the RLC be phos- 
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amino acid(s) within the RLC whose phosphorylation was 
responsible  for  the  regulation  of ATPase  and  mechano- 
chemical activity. Unfortunately, no one has as yet directly 
determined which site(s) is phosphorylated in Dictyostelium 
myosin II  RLCs that  have been  phosphorylated in  vivo. 
Nevertheless, Ostrow et al. (20) have provided a convincing 
argument that serine 13 in the RLC is the major site phos- 
phorylated in vivo in nonsynchronized, growing cells. First, 
they showed by NH~-terminal protein sequencing that RLCs, 
which were made in E. coli and phosphorylated in vitro with 
the cloned MLCK, are phosphorylated on serine 13. When 
serine 13 was then converted into an alanine residue by site- 
directed  mutagenesis  (creating  "S13,¢'  RLC),  and  these 
RLCs expressed in E. coli,  they could no longer be phos- 
phorylated by MCLK in vitro. Moreover, when intact myo- 
sin II containing the S13A RLC subunit was purified from 
Dictyostelium  transformants,  it  was  also  not  possible  to 
phosphorylate the heavy chain-associated RLC in vitro.  In 
a final and very important control experiment, Dictyostelium 
cells were labeled metabolically with 32p and myosin II was 
rapidly immunoprecipitated from whole cell extracts with an 
anti-heavy chain antibody. Whereas the RLC of immunopre- 
cipitated wild type myosin contained significant amounts of 
radioactive phosphate, the RLC of S13A was essentially de- 
void of radioactive phosphate.  This latter result provided 
strong evidence that serine  13  is  the principal  target  for 
MLCK(s) in vivo. 
As anticipated, Ostrow et al. (20) found that purified S13A 
myosin exhibited  a  basal  actin-activated ATPase  activity 
(•20  nmole/min/mg), equivalent to the activity reported for 
myosin II  whose  RLC  had  been  fully dephosphorylated 
using a protein phosphatase (16). The big surprise was that 
cells expressing S13A myosin were essentially normal! Os- 
trow et al.  (20)  showed specifically that S13A myosin was 
able to rescue the defects in cytokinesis, development and 
myosin II heavy chain localization seen in RLC null cells. 
It would appear, therefore, that placement of phosphate on 
the light chain, as well as on the heavy chain, is not essential 
for myosin II-dependent functions in Dictyostelium.  In the 
Dictyostelium  knockout business,  the  normal explanation 
given for relatively subtle phenotypes, which is the existence 
of multiple,  functionally redundant isoforms (11), simply 
does  not  apply  to  the  analysis of cells  expressing  non- 
phosphorylatable myosin II molecules. It would seem, there- 
fore, that as long as Dictyostelium  myosin II can assemble 
into filaments, it can support functions that are absolutely 
myosin II-dependent even when the filaments are not partic- 
ularly active. 
With regard to light chain phosphorylation specifically, 
how surprising are the results of Ostrow et al. (20)? If one 
considers only the effect of RLC phosphorylation on the 
actin-activated ATPase of myosin II, the results are perhaps 
not totally surprising, since the relatively small activation of 
steady state ATPase (approximately sixfold) is almost more 
modulatory than  regulatory  (especially  compared  to  the 
RLC-based regulation of vertebrate smooth and nonmuscle 
myosins). It is likely, however, that the real degree of activa- 
tion of Dictyostelium  myosin II by RLC phosphorylation, 
which would be more accurately determined using single 
turnover experiments (33),  is considerably higher than the 
approximately sixfold number obtained from steady state 
measurements.  If one also  considers the  early results of 
Griffiths et al. (10), which suggest that RLC phosphorylation 
is required for myosin II to move on actin (i.e., that for de- 
phosphorylated myosin II, ATPase,  and motility are com- 
pletely uncoupled), then the results of Ostrow et al. (20) be- 
come truly amazing.  As  mentioned above,  however,  that 
early finding has not been repeated, and for now should per- 
haps be viewed with some skepticism. Indeed, the best way 
to unequivocally answer this question would be to use the 
S13A myosin made by Ostrow et al. (20) in a motility assay! 
While heavy and light chain phosphorylation of myosin II 
are not essential for Dictyostelium cells to perform several 
myosin II-dependent functions, it would be a mistake to con- 
clude that these phosphorylations are not important for op- 
timal cellular function. The modulation of myosin II assem- 
bly and ATPase activity by these phosphorylations could 
very easily improve the efficiency of many cellular processes 
to an extent which, while difficult to measure in a statisti- 
cally significant way, would provide a striking selective ad- 
vantage over time. For example, as pointed out by Ostrow et 
al. (20), a 5 % increase in the efficiency  of cytokinesis, which 
might well be the difference between regulated and nonregu- 
lated myosin II,  would result in a  growth advantage that 
would manifest itself  on a time scale of weeks to months. Ob- 
viously,  even  minute  improvements  in  the  efficiency  of 
processes that either require myosin II or simply involve my- 
osin II,  would on an evolutionary scale provide a  strong 
selective advantage. Indeed the mere fact that light and heavy 
chain phosphorylations exist  for Dictyostelium  myosin II 
strongly suggests that they evolved because of the selective 
advantage that they provide. 
The next logical step in the analysis of these myosin II 
phosphorylation site mutants is  clearly the application of 
functional tests that can detect subtle differences between 
control and experiment cells. For example, detailed motility 
assays of cells expressing 3XALA myosin and S13A myosin 
using quantitative video microscopy could very well detect 
important differences in the speed and orientation of crawl- 
ing cells and in the dynamics of their shape change (37). 
Such tests could also be performed under artificial "load" 
conditions (e.g., locomotion on a highly adhesive surface) 
which may amplify the differences between mutant and wild 
type  cells.  Application  of  functional  tests  which  yield 
graded, quantifiable responses will also be useful in defining 
differences between wild type cells and phosphorylation site 
mutants. These could include measurements of cortical ten- 
sion  (22)  and  measurements  of  the  speed  with  which 
cytoskeletal preparations can contract (17). It seems highly 
likely that the tendency for 3XALA myosin to over assemble 
in vivo, and the low ATPase activity exhibited by S13A myo- 
sin, will be reflected  in some of these assays of whole cell 
behavior. 
In addition to the studies described above,  the ability to 
distinguish phosphorylated myosin II  from dephosphory- 
lated myosin II using antibodies that are specific  for each 
form, when coupled with immunofluorescence localizations, 
would be of great benefit in understanding the role of myosin 
II phosphorylation in cell function. Just such an approach 
has recently been used by Baines and co-workers  (Baines, 
I. C., A. Corigliano-Murphy, and E. D. Korn, manuscript 
submitted for publication) for several of the Acanthamoeba 
myosin I heavy chain isoforms. Secondly, while the immuno- 
Hammer Regulation of Dictyostelium Myosin 1l by Phosphorylation  1781 precipitation data of Ostrow et al. (20) provides strong evi- 
dence that serine 13 in the RLC is the principal site for phos- 
phorylation  in growing ceils, this data does not absolutely 
rule out other physiologically important phosphorylations of 
the RLC (Smith, J. L., L. A. Silveira,  and J. A. Spudich. 
1992. Mol. Biol.  Cell. 3:45a; Silveira,  L. A., J. A. Smith, 
and J. A. Spudich.  1993. Mol. Biol.  Cell. 3:44a). Some of 
these phosphorylations might only be detected  in immuno- 
precipitated  myosin when cells have been synchronized  to 
divide or undergo chemotactic aggregation.  Myosin 1I may 
also be compartmentali7ed  in cells,  so it is possible that a 
phosphorylated," active  population  of myosin II molecules 
that are critical for cell function could be largely missed in 
immunoprecipitation  experiments  if the bulk of the cellular 
myosin II is unphosphorylated.  Furthermore, some of these 
additional,  putative  RLC phosphorylations  may have their 
desired  effect in vivo at relatively  low stoichiometries.  Fi- 
nally, much work is needed to elucidate  how the light and 
heavy chain  kinases  for Dictyostelium  myosin II are regu- 
lated by signal transduction pathways. In this regard, the two 
myosin II heavy chain  kinases  sequenced so far reveal in- 
teresting  motifs in their primary structure which probably 
relate to how they are regulated in vivo (9, 24). 
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